Legal Representation
Attorney
Ronald A. DiCerbo
USPTO Deadlines
Next Deadline
2115 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-05-20)
Due Date
May 20, 2031
Grace Period Ends
November 20, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
38 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
May 20, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
May 20, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Apr 29, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
Apr 29, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
Feb 21, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Feb 20, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
Dec 10, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
Dec 10, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
Jun 25, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Apr 30, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Apr 30, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Apr 10, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Mar 26, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Mar 26, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Mar 26, 2024 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Mar 26, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Mar 26, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Nov 9, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Nov 8, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Nov 8, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Aug 23, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Aug 23, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Aug 23, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Aug 23, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Aug 22, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Aug 22, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jun 30, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Jun 30, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Jun 30, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jun 30, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
Jun 30, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
May 22, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
May 22, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
Feb 22, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Feb 22, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Feb 22, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Dec 3, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Feb 23, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 042
Genetic and genomic testing services in the field of cancer, for scientific research purposes; molecular profiling of tumors for scientific research purposes; genetic and genomic testing, namely sequencing and profiling services for scientific research purposes; genetic and genomic analysis services for scientific research purposes; providing temporary use of online non-downloadable software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations; DNA screening and analysis services; genomic and genetic testing services relating to drug development and clinical trials for scientific research purposes; providing temporary use of online non-downloadable software being genetic and genomic sequencing technology in the fields of cancer, genetics, and genomics
First Use Anywhere:
20220400
First Use in Commerce:
20220400
Class 044
Genetic and genomic testing services in the field of cancer, for medical purposes; medical testing in the nature of molecular profiling of tumors for diagnostic or treatment purposes; genetic and genomic testing, namely sequencing and profiling services for medical purposes; genetic and genomic medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical testing in the nature of DNA screening and analysis for diagnostic or treatment purposes; genomic and genetic testing services relating to drug development and clinical trials for medical purposes
First Use Anywhere:
20220400
First Use in Commerce:
20220400
Classification
International Classes
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"ARRAY"